TITLE

Reduction of Reaction due to Iron Dextran Infusion using Chloroquine

AUTHOR(S)
Byles, A. B.; D'sa, Avita
PUB. DATE
September 1970
SOURCE
British Medical Journal;9/12/1970, Vol. 3 Issue 5723, p625
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64097970

 

Related Articles

  • Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia. Ricardo Friedrisch, João; Delfini Cançado, Rodolfo // Revista Brasileira de Hematologia e Hemoterapia;Nov/Dec2015, Vol. 37 Issue 6, p400 

    Nutritional iron deficiency anemia is the most common deficiency disorder, affecting more than two billion people worldwide. Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia, but in many conditions, oral iron is less than ideal mainly because of...

  • Clinical Benefits Justify Additional Cost of Iron Dextran.  // Kidney;Jul/Aug99, Vol. 8 Issue 4, p171 

    Studies the cost effectiveness impact of iron dextran on hemodialysis patients' use of epoietin alfa and blood. Average epoietin alfa dosage; Incremental cost-effectiveness of iron dextran per successful treatment; Reduction in the need for blood transfusions with iron dextran administration.

  • Toxicity of parenteral iron dextran therapy. Burns, David L.; Pomposelli, James J. // Kidney International Supplement;Mar1999, Issue 69, pS-119 

    Investigates the efficacy of parenteral iron dextran therapy on iron repletion in patients with iron-deficiency anemia. Toxicities associated with iron dextran use; Causes of iron deficiency; Mechanisms leading to iron dextran-induced symptoms.

  • Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Auerbach, M.; Al Talib, K. // Kidney International;Mar2008, Vol. 73 Issue 5, p528 

    Serious adverse events that occur with the administration of iron dextran are due to the high molecular weight preparations. Conclusions that iron sucrose and ferric gluconate are safer than iron dextran may be premature. Published literature comparing safety profiles of available parenteral...

  • iron dextran injection.  // Taber's Cyclopedic Medical Dictionary;2005, p1142 

    A definition of the medical term "iron dextran injection" is presented. It refers to a preparation of iron suitable for parenteral use. Because of the risk of anaphylaxis, a test dose should be given prior to infusion of iron. The definition is from the "Taber's Cyclopedic Medical Dictionary,"...

  • Drugs in cerebral and peripheral arterial disease. Lowe, Gordon D.O. // BMJ: British Medical Journal (International Edition);2/24/90, Vol. 300 Issue 6723, p524 

    Presents drugs used in treating cerebral and peripheral arterial disease in Great Britain. Decrease on the packed cell volume by dextran infusions; Reduction of cerebral oedema by glycerol; Increase of oxidative metabolism by Naftidrofuryl.

  • In vivo detection of acute rat renal allograft rejection by MRI with USPIO particles. Ye, Qing; Yang, Dewen; Williams, Mangay; Williams, Donald S; Pluempitiwiriyawej, Charnchai; Moura, José M.F; Ho, Chien; Moura, José M F // Kidney International;Mar2002, Vol. 61 Issue 3, p1124 

    Background: Magnetic resonance imaging (MRI) for non-invasively detecting renal rejection was developed by monitoring the accumulation of macrophages labeled with dextran-coated ultrasmall superparamagnetic iron oxide (USPIO) particles at the rat renal allografts during acute...

  • Iron Dextran Injection.  // AHFS Consumer Medication Information;Oct2019, p1 

    Iron dextran injection is used to treat iron-deficiency anemia (a lower than normal number of red blood cells due to too little iron) in people who cannot be treated with iron supplements taken by mouth. Iron dextran injection is in a class of medications called iron replacement products. It...

  • Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease. Koutroubakis, Ioannis; Oustamanolakis, Pantelis; Karakoidas, Christos; Mantzaris, Gerassimos; Kouroumalis, Elias; Koutroubakis, Ioannis E; Mantzaris, Gerassimos J; Kouroumalis, Elias A // Digestive Diseases & Sciences;Aug2010, Vol. 55 Issue 8, p2327 

    Background: Intravenous iron has been suggested as a safe and effective treatment of anemia complicating inflammatory bowel disease (IBD). Low molecular weight (LMW) iron dextran has the ability to administer the patient's total iron requirement in a single infusion.Aims:...

  • Chloroquine Is a Zinc Ionophore. Xue, Jing; Moyer, Amanda; Peng, Bing; Wu, Jinchang; Hannafon, Bethany N.; Ding, Wei-Qun // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Chloroquine is an established antimalarial agent that has been recently tested in clinical trials for its anticancer activity. The favorable effect of chloroquine appears to be due to its ability to sensitize cancerous cells to chemotherapy, radiation therapy, and induce apoptosis. The present...

Share

Read the Article

Other Topics